White blood cell differentials enrich whole blood expression data in the context of acute cardiac allograft rejection

Bioinformatics and Biology Insights

Volumn 6, Issue , 2012, Pages 49-58

  Shannon, Casey P ^a,c   Hollander, Zsuzsanna ^a,b,c   Wilson McManus, Janet ^a,c   Balshaw, Robert ^a,b   Ng, Raymond T ^a,b,c   McMaster, Robert ^a,b   McManus, Bruce M ^a,b,c   Keown, Paul A ^a,b   Tebbutt, Scott J ^a,b,c  

^a NCE CECR PROOF Centre of Excellence   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

Author keywords

Cell specific expression; Deconvolution; Heart; Microarray expression; Transplantation

Indexed keywords

ADAM METALLOPEPTIDASE DOMAIN 8; ADAM PROTEIN; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; DNA DEPENDENT PROTEIN KINASE; FLICE INHIBITORY PROTEIN; MONOCARBOXYLATE TRANSPORTER 4; TAURINE TRANSPORTER; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ALGORITHM; ARTICLE; BLOOD SAMPLING; CARDIAC GRAFT REJECTION; CELL SPECIFIC SIGNIFICANCE ANALYSIS OF MICROARRAY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; HEART TRANSPLANTATION; HUMAN; LEUKOCYTE COUNT; MALE; MICROARRAY ANALYSIS; MOLECULAR PROBE; MONOCYTE; STATISTICAL ANALYSIS;

EID: 84860857099     PISSN: None     EISSN: 11779322     Source Type: Journal    
DOI: 10.4137/BBI.S9197     Document Type: Article

References (45)

1. Lin D, et al. Whole blood genomic biomarkers of acute cardiac allograft rejection. The Journal of Heart and Lung Transplantation. 2009;28:927-935.
2. Hollander Z, et al. Whole blood biomarkers of acute cardiac allograft rejection: Double-crossing the biopsy. Transplantation. 2010;90:1388-1393.
3. Alakulppi NS, Kyllönen LE, Partanen J, Salmela KT, Laine JT. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules. Transplantation. 2007;83:791-798.
4. Günther OP, et al. Functional genomic analysis of peripheral blood during early acute renal allograft rejection. Transplantation. 2009;88:942-951.
5. Brouard S, et al. Identification of a peripheral blood transcriptional bio-marker panel associated with operational renal allograft tolerance. Proceedings of the National Academy of Sciences. 2007;104:15448-15453.
6. Freue GVC, et al. Proteomic signatures in plasma during early acute renal allograft rejection. Molecular & Cellular Proteomics. 2010;9:1954-1967.
7. Shen-Orr SS, et al. Cell type-specific gene expression differences in complex tissues. Nat Meth. 2010;7:287-289.
8. Chaussabel D, Pascual V, Banchereau J. Assessing the human immune system through blood transcriptomics. BMC biology. 2010;8:84.
9. Mesko B, Poliska S, Nagy L. Gene expression profiles in peripheral blood for the diagnosis of autoimmune diseases. Trends in Molecular Medicine. 2011;17:223-233.
10. Xu Q, et al. Investigation of variation in gene expression profling of human blood by extended principle component analysis. PLoS ONE. 2011;6:e26905.
11. Isse K, et al. Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high- resolution whole-slide digital imaging, and automated image analysis. Clinics in Liver Disease. 2010;14:669-685.
12. Kuhn A, Thu D, Waldvogel HJ, Faull RLM, Luthi-Carter R. Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain. Nature Methods. 2011;8:945-947.
13. Gaujoux R, Seoighe C. Semi-supervised nonnegative matrix factorization for gene expression deconvolution: A case study. Infection, Genetics and Evolution. 2011. doi:10.1016/j.meegid.2011.08.014.
14. Feezor RJ, et al. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiological Genomics. 2004;19:247-254.
15. Debey S, et al. Comparison of different isolation techniques prior gene expression profling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J. 2004;4:193-207.
16. Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS ONE. 2009;4:e6098.
17. Bolen C, Uduman M, Kleinstein S. Cell Subset prediction for blood genomic studies. BMC bioinformatics. 2011;12:258.
18. Subramanian A, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:15545-15550.
19. Wu C, et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009; 10:R130.
20. Su AI, et al. A gene atlas of the mouse and human protein-encoding tran-scriptomes. Proc Natl Acad Sci U S A. 2004;101:6062-6067.
21. Kirk P, et al. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 2000;19:3896-3904.
22. Murray CM, et al. Monocarboxylate transporter MCT1 is a target for immu-nosuppression. Nat Chem Biol. 2005;1:371-376.
23. Bueno V, et al. The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse. Transplantation. 2007;84:1204-1207.
24. Ekberg H, et al. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat. Transplantation. 2007;84: 1191-1199.
25. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Bröer S. The low-affnity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J. 2000;350:219-227. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1221245/
26. Samuvel DJ, Sundararaj KP, Nareika A, Lopes-Virella MF, Huang Y. Lactate boosts TLR4 signaling and NF-κB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up- regulation. The Journal of Immunology. 2009;182:2476-2484.
27. Methe H, Zimmer E, Grimm C, Nabauer M, Koglin J. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation. 2004;78:1324-1331.
28. Kim C, Cha YN. Production of reactive oxygen and nitrogen species in phagocytes is regulated by taurine chloramine. Taurine. 2009;643(7): 463-472.
29. Kim JW, Kim C. Inhibition of LPS-induced NO production by taurine chloramine in macrophages is mediated though Ras-ERK-NF-κB. Biochemical Pharmacology. 2005;70:1352-1360.
30. Kim C, Jang JS, Cho MR, Agarawal SR, Cha YN. Taurine chloramine induces heme oxygenase-1 expression via Nrf 2 activation in murine macrophages. International Immunopharmacology. 2010;10:440-446.
31. Barua M, Liu Y, Quinn MR. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: Decreased NF-κB activation and IκB kinase activity. The Journal of Immunology. 2001;167:2275-2281.
32. Park E, Jia J, Quinn MR, Schuller-Levis G. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clinical Immunology. 2002;102:179-184.
33. Richens J, et al. The detection of ADAM8 protein on cells of the human immune system and the demonstration of its expression on peripheral blood B cells, dendritic cells and monocyte subsets. Immunobiology. 2007;212:29-38.
34. Yoshiyama K, Higuchi Y, Kataoka M, Matsuura K, Yamamoto S. CD156 (human ADAM8): expression, primary amino acid sequence, and gene location. Genomics. 1997;41:56-62.
35. Knolle M, Owen C. ADAM8 Limits allergic airway infammation in mice by increasing macrophage apoptosis. American Journal of Respiratory and Critical Care Medicine. 2009;179:A2234.
36. Kavuri SM, et al. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. J Biol Chem. 2011;286:16631-16646.
37. Lu P, Nakorchevskiy A, Marcotte EM. Expression deconvolution: a rein-terpretation of DNA microarray data reveals dynamic changes in cell populations. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:10370.
38. Abbas AR, et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun. 2005;6:319-331.
39. Stewart S, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. The Journal of Heart and Lung Transplantation. 2005;24:1710-1720.
40. Gentleman RC, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome biology. 2004;5:R80.
41. Irizarry RA, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-264.
42. Bolstad BM. Low-level analysis of high-density oligonucleotide array data: background, normalization and summarization. 2004.
43. Cohen Freue G V, et al. MDQC: a new quality assessment method for microar-rays based on quality control reports. Bioinformatics. 2007;23:3162-3169.
44. Bolstad BM, Irizarry R, Åstrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-193.
45. Tusher VG. Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences. 2001;98:5116-5121.